ZOMIG is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Impax Specialty Pharma. The primary component is Zolmitriptan.
Product ID | 64896-671_51dce449-5220-4582-ba49-b10580ec5009 |
NDC | 64896-671 |
Product Type | Human Prescription Drug |
Proprietary Name | ZOMIG |
Generic Name | Zolmitriptan |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2012-04-02 |
Marketing Category | NDA / NDA |
Application Number | NDA020768 |
Labeler Name | Impax Specialty Pharma |
Substance Name | ZOLMITRIPTAN |
Active Ingredient Strength | 3 mg/1 |
Pharm Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-04-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020768 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-04-02 |
Marketing Category | NDA |
Application Number | NDA020768 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-04-02 |
Ingredient | Strength |
---|---|
ZOLMITRIPTAN | 2.5 mg/1 |
SPL SET ID: | df93b636-103f-4fb5-26b6-50f639e29b1d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
21695-955 | ZOMIG | Zolmitriptan |
68258-7103 | ZOMIG | ZOMIG |
64896-682 | ZOMIG | ZOMIG |
64896-672 | ZOMIG | ZOMIG |
64896-681 | ZOMIG | ZOMIG |
64896-671 | ZOMIG | ZOMIG |
0115-0671 | Zolmitriptan | Zolmitriptan |
0115-0672 | Zolmitriptan | Zolmitriptan |
16571-803 | Zolmitriptan | Zolmitriptan |
16571-804 | Zolmitriptan | Zolmitriptan |
27241-021 | Zolmitriptan | Zolmitriptan |
27241-022 | Zolmitriptan | Zolmitriptan |
31722-458 | ZOLMITRIPTAN | ZOLMITRIPTAN |
31722-459 | ZOLMITRIPTAN | ZOLMITRIPTAN |
33342-112 | Zolmitriptan | Zolmitriptan |
33342-113 | Zolmitriptan | Zolmitriptan |
33342-139 | Zolmitriptan | Zolmitriptan |
33342-140 | Zolmitriptan | Zolmitriptan |
45802-711 | zolmitriptan | zolmitriptan |
46708-181 | Zolmitriptan | Zolmitriptan |
46708-182 | Zolmitriptan | Zolmitriptan |
46708-462 | Zolmitriptan | Zolmitriptan |
46708-463 | Zolmitriptan | Zolmitriptan |
50742-625 | Zolmitriptan | Zolmitriptan |
50742-626 | Zolmitriptan | Zolmitriptan |
55700-943 | Zolmitriptan | Zolmitriptan |
55700-944 | Zolmitriptan | Zolmitriptan |
55801-322 | Zolmitriptan | Zolmitriptan |
55801-323 | Zolmitriptan | Zolmitriptan |
59746-432 | Zolmitriptan | Zolmitriptan |
59746-433 | Zolmitriptan | Zolmitriptan |
59746-461 | Zolmitriptan OD | Zolmitriptan |
59746-462 | Zolmitriptan OD | Zolmitriptan |
0115-0691 | Zolmitriptan Orally Disintegrating | Zolmitriptan |
0115-0692 | Zolmitriptan Orally Disintegrating | Zolmitriptan |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZOMIG 74719034 2175295 Live/Registered |
Wellcome Foundation Limited, The 1995-08-22 |